Brief: Sinopharm Group Posts FY Profit Attributable Of RMB7.16 BLN
March 23 (Reuters) - Sinopharm Group Co Ltd 1099.HK: FINAL DIVIDEND OF RMB0.69 PER ORDINARY SHARE IS TO BE PROPOSED FY PROFIT ATTRIBUTABLE RMB7.16 BILLION FY REVENUE RMB575.17 BILLION Further company coverage: 1099.HK ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Sinopharm
See all newsBrief: Sinopharm Group Says 9M Sinopharm Accord Net Income Attributable RMB952.5 Million (Oct 20)
Medical products distributor Sinopharm Group's prelim 9-month revenue slips
Brief: BlackRock's Long Position In H Shares Of Sinopharm Reduces To 9.23% On Oct 13, HKEX Shows
Sinopharm interim revenue edges down on softness in pharmaceutical distribution business
Brief: Sinopharm Group To Sell 30.13% Stake In China National Medicines Guorui Pharmaceutical For